Outcome and risk factor of immune‐related adverse events and pneumonitis in patients with advanced or postoperative recurrent non‐small cell lung cancer treated with immune checkpoint inhibitors

BACKGROUND: Non‐small cell lung cancer (NSCLC) patients with pre‐existing respiratory diseases have been excluded in clinical trials of immune checkpoint inhibitor (ICI) therapy, and it is unknown whether the same degree of response can be expected as that in patients without pre‐existing respirator...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Thorac Cancer
Main Authors: Isono, Taisuke, Kagiyama, Naho, Takano, Kenji, Hosoda, Chiaki, Nishida, Takashi, Kawate, Eriko, Kobayashi, Yoichi, Ishiguro, Takashi, Takaku, Youtaro, Kurashima, Kazuyoshi, Yanagisawa, Tsutomu, Takayanagi, Noboru
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley & Sons Australia, Ltd 2020
Fag:
Original Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7812074/
https://ncbi.nlm.nih.gov/pubmed/33201587
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13736
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker